Celcuity Inc. (CELC)Healthcare | Biotechnology | Minneapolis, United States | NasdaqCM
88.44 USD
-4.80
(-5.148%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 90.10 +1.66 (1.877%) ⇧ (Aug. 28, 2026, 7:49 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3 a.m. EDT
Celcuity presents a compelling turnaround story backed by tangible clinical milestones, including a first FDA approval for a cancer drug and positive breast cancer trial data. The long-term price trajectory reflects this recovery, surging nearly 100 percent over the past seven years with no recent consecutive annual declines, validating the market's renewed confidence in the pipeline. While the balance sheet remains neutral with cash matching debt obligations, the strong analyst consensus and robust liquidity position support a solid investment case. Short-term momentum is building off the regulatory wins, though technicals remain below the 200-day average, creating a consolidation zone before the next leg up. The absence of a dividend is appropriate for a growth-stage biotech focused on capitalizing on its pipeline. Investors should view this as a high-conviction recovery play rather than a value income vehicle. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.078963 |
| AutoETS | 0.078964 |
| MSTL | 0.086977 |
| AutoTheta | 0.111190 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 0.23 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.122 |
| Excess Kurtosis | -0.41 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 4,327,538,176 |
| Forward P/E | -1105.50 |
| Beta | 0.20 |
| Website | https://www.celcuity.com |
As of Aug. 22, 2026, 3 a.m. EDT: Speculators are positioning for significant upside potential with heavy call open interest at strikes ranging from 100 to 220, indicating a bullish thesis on the underlying asset. However, implied volatility is skewed higher on the put side, suggesting active hedging against downside risk despite the recent price action.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.7402016 |
| Address1 | 2,800 Campus Drive |
| Address2 | Suite 140 |
| All Time High | 151.02 |
| All Time Low | 4.03 |
| Ask | 88.86 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 749,350 |
| Average Daily Volume3 Month | 1,508,491 |
| Average Volume | 1,508,491 |
| Average Volume10Days | 749,350 |
| Beta | 0.2 |
| Bid | 89.04 |
| Bid Size | 1 |
| Board Risk | 9 |
| Book Value | -0.261 |
| City | Minneapolis |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 88.44 |
| Current Ratio | 8.931 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 92.475 |
| Day Low | 88.225 |
| Display Name | Celcuity |
| Earnings Call Timestamp End | 1,786,653,000 |
| Earnings Call Timestamp Start | 1,786,653,000 |
| Earnings Timestamp | 1,786,651,200 |
| Earnings Timestamp End | 1,794,427,200 |
| Earnings Timestamp Start | 1,794,427,200 |
| Ebitda | -208,479,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -20.759 |
| Enterprise Value | 4,327,879,168 |
| Eps Current Year | -4.39 |
| Eps Forward | -0.08 |
| Eps Trailing Twelve Months | -4.08 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 94.2288 |
| Fifty Day Average Change | -5.7887955 |
| Fifty Day Average Change Percent | -0.0614334 |
| Fifty Two Week Change Percent | 74.02016 |
| Fifty Two Week High | 151.02 |
| Fifty Two Week High Change | -62.58 |
| Fifty Two Week High Change Percent | -0.4143822 |
| Fifty Two Week Low | 44.42 |
| Fifty Two Week Low Change | 44.020004 |
| Fifty Two Week Low Change Percent | 0.99099517 |
| Fifty Two Week Range | 44.42 - 151.02 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,505,914,200,000 |
| Float Shares | 29,717,326 |
| Forward Eps | -0.08 |
| Forward P E | -1,105.5 |
| Free Cashflow | -72,001,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 155 |
| Fullday Change | -4.8 |
| Fullday Change Percent | -5.148 |
| Fullday Price | 90.1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.102299996 |
| Held Percent Institutions | 1.10324 |
| Implied Shares Outstanding | 48,931,908 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota. |
| Long Name | Celcuity Inc. |
| Market | us_market |
| Market Cap | 4,327,538,176 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_254573983 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -226,482,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,564,857,697 |
| Number Of Analyst Opinions | 11 |
| Open | 91.9 |
| Operating Cashflow | -191,706,000 |
| Operating Margins | 0.0 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | (763) 392-0123 |
| Post Market Change | 1.659996 |
| Post Market Change Percent | 1.8769742 |
| Post Market Price | 90.1 |
| Post Market Time | 1,787,960,971 |
| Previous Close | 93.24 |
| Price Eps Current Year | -20.145786 |
| Price Hint | 2 |
| Price To Book | -338.8506 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.68 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.16667 |
| Region | US |
| Regular Market Change | -4.8 |
| Regular Market Change Percent | -5.148 |
| Regular Market Day High | 92.475 |
| Regular Market Day Low | 88.225 |
| Regular Market Day Range | 88.225 - 92.475 |
| Regular Market Open | 91.9 |
| Regular Market Previous Close | 93.24 |
| Regular Market Price | 88.44 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 610,267 |
| Return On Assets | -0.2578 |
| Return On Equity | -14.33703 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 48,931,908 |
| Shares Percent Shares Out | 0.21530001 |
| Shares Short | 10,535,416 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 11,152,374 |
| Short Name | Celcuity Inc. |
| Short Percent Of Float | 0.32299998 |
| Short Ratio | 6.73 |
| Source Interval | 15 |
| State | MN |
| Symbol | CELC |
| Target High Price | 177.0 |
| Target Low Price | 140.0 |
| Target Mean Price | 161.09091 |
| Target Median Price | 163.0 |
| Total Cash | 754,044,032 |
| Total Cash Per Share | 15.41 |
| Total Debt | 754,385,024 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 105.93065 |
| Two Hundred Day Average Change | -17.490646 |
| Two Hundred Day Average Change Percent | -0.16511412 |
| Type Disp | Equity |
| Volume | 610,267 |
| Website | https://www.celcuity.com |
| Zip | 55,441 |